Responses
Scientific Abstracts
Abstracts accepted for publication
Innate immunity in rheumatic diseases
AB0071 Characterization of NNC141-0100, a therapeutic antibody targeting inhibitory CD94/NKG2A receptors expressed in inflamed joints of rheumatoid arthritis patients
Compose a Response to This Article
Other responses
No responses have been published for this article.